Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 39 of 39 Results Clear All
Advanced imaging and computational technology facilitate the search for cures.
Finkbeiner Lab
Brianna Bibel, an undergraduate student at St. Mary’s College of California, has joined the lab of Dr. Steve Finkbeiner for the summer after receiving a 2015 Donald A. King Summer Research Fellowship from the Huntington’s Disease Society of America (HDSA).
Huntington’s Disease Finkbeiner Lab
Revelations about a key cellular pathway have important implications for neurodegenerative diseases like ALS and frontotemporal dementia.
Finkbeiner Lab
Grants are to be used for innovative and transformative research into the detailed cell biology of the brain.
Finkbeiner Lab
Revolutionary imaging technique reveals that a unique protein interaction may be key to driving the most common genetic cause of Parkinson’s disease
Finkbeiner Lab
SAN FRANCISCO, CA—Alzheimer’s, Huntington’s, Parkinson’s. Names forever linked to what they represent: diseases that ravage the brain’s neurons and leave entire regions to wither and die.
Finkbeiner Lab Huntington’s Disease
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have deciphered how a protein called Arc regulates the activity of neurons—providing much-needed clues into the brain’s ability to form long-lasting memories.
Finkbeiner Lab
San Francisco, CA—The most devastating aspect of Parkinson’s disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may not be the millions around the world and their families who suffer each day from the disease’s harmful effects.
Finkbeiner Lab
CAMBRIDGE, MA and SAN FRANCISCO, CA—The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process.
ALS Finkbeiner Lab
